These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 28472255)

  • 21. Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.
    Ho J; Jelfs P; Sintchencko V
    J Antimicrob Chemother; 2013 Dec; 68(12):2915-20. PubMed ID: 23838950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of complex tuberculosis cases: a focus on drug-resistant tuberculous meningitis.
    Garg RK; Rizvi I; Malhotra HS; Uniyal R; Kumar N
    Expert Rev Anti Infect Ther; 2018 Nov; 16(11):813-831. PubMed ID: 30359140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa.
    Patel VB; Padayatchi N; Bhigjee AI; Allen J; Bhagwan B; Moodley AA; Mthiyane T
    Clin Infect Dis; 2004 Mar; 38(6):851-6. PubMed ID: 14999630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
    Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
    de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE
    Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.
    Salindri AD; Sales RF; DiMiceli L; Schechter MC; Kempker RR; Magee MJ
    Ann Am Thorac Soc; 2018 Mar; 15(3):331-340. PubMed ID: 29131662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of pulmonary tuberculosis in patients with discordant phenotypic isoniazid resistance testing.
    Kim S; Lee H; Park HY; Jeon K; Huh HJ; Lee NY; Jeong BH
    Respir Med; 2017 Dec; 133():6-11. PubMed ID: 29173450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of isoniazid-resistant miliary tuberculosis in which tuberculous meningitis paradoxically developed despite systemic improvement.
    Ikegame S; Wakamatsu K; Fujita M; Nakanishi Y; Harada M; Kajiki A
    J Infect Chemother; 2011 Oct; 17(5):689-93. PubMed ID: 21327690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculous meningitis: advances in diagnosis and treatment.
    Török ME
    Br Med Bull; 2015 Mar; 113(1):117-31. PubMed ID: 25693576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug susceptibility profiling of tuberculous meningitis.
    Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoroquinolones in the management of tuberculous meningitis: Systematic review and meta-analysis.
    Rizvi I; Malhotra HS; Garg RK; Kumar N; Uniyal R; Pandey S
    J Infect; 2018 Oct; 77(4):261-275. PubMed ID: 30017610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    Rockwood N; Sirgel F; Streicher E; Warren R; Meintjes G; Wilkinson RJ
    J Infect Dis; 2017 Sep; 216(6):632-640. PubMed ID: 28934422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis.
    Te Brake L; Dian S; Ganiem AR; Ruesen C; Burger D; Donders R; Ruslami R; van Crevel R; Aarnoutse R
    Int J Antimicrob Agents; 2015 May; 45(5):496-503. PubMed ID: 25703312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoniazid Resistance and Dosage as Treatment for Patients with Tuberculosis.
    Nagel S; Streicher EM; Klopper M; Warren RM; Van Helden PD
    Curr Drug Metab; 2017; 18(11):1030-1039. PubMed ID: 29086682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system].
    Isakova ZhT
    Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of diverse mutations in isoniazid- and rifampicin-resistant Mycobacterium tuberculosis isolates from autochthonous and immigrant populations of Saudi Arabia.
    Varghese B; Shoukri M; Memish Z; Abuljadayel N; Alhakeem R; Alrabiah F; Al-Hajoj S
    Microb Drug Resist; 2014 Dec; 20(6):623-31. PubMed ID: 25014484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Description of primary multidrug-resistant tuberculous meningitis in an Italian child.
    Mauro MV; Cavalcanti P; Ledonne R; Giraldi C; Sperlì D
    Microb Drug Resist; 2012 Feb; 18(1):71-3. PubMed ID: 21711151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of high-dose rifampicin in the management of tuberculosis meningitis: Systematic review and meta-analysis.
    Charlie L; Abay SM; Tesfaye A; Mlera RN; Mwango S; Goretti M
    Int J Mycobacteriol; 2021; 10(3):312-319. PubMed ID: 34494572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.